Evogliptin
- Generic Name
- Evogliptin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H26F3N3O3
- CAS Number
- 1222102-29-5
- Unique Ingredient Identifier
- 09118300L7
- Background
Evogliptin has been used in trials studying the treatment and screening of Osteoporosis, Renal Impairment, Type 2 Diabetes Mellitus, Diabetes Mellitis Type 2, and Diabetes Mellitus, Type 2.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath